Medirom Healthcare Technologies (MRM) Invested Capital (2019 - 2025)

Medirom Healthcare Technologies has reported Invested Capital for 7 years, with the latest figure at $6.4 million in Q2 2025.

• For the quarter ending Q2 2025, Invested Capital rose 974.4% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2025 stood at $6.4 million (up 404.08% YoY), and the FY2024 full-year result was $10.6 million, up 402.46% from the prior year.
• Invested Capital for Q2 2025 stood at $6.4 million, down from $10.6 million in the prior quarter.
• The five-year high for Invested Capital was $10.6 million in Q4 2024, with the low at -$405474.3 in Q4 2021.
• Average Invested Capital over 5 years is $3.0 million, with a median of $1.4 million recorded in 2023.
• Year-over-year, Invested Capital tumbled 105.78% in 2021 and surged 974.4% in 2025.
• Tracing MRM's Invested Capital over 5 years: stood at -$405474.3 in 2021, then surged by 169.46% to $281646.3 in 2022, then soared by 647.74% to $2.1 million in 2023, then surged by 402.46% to $10.6 million in 2024, then tumbled by 39.53% to $6.4 million in 2025.
• The last three Invested Capital figures came in at $6.4 million (Q2 2025), $10.6 million (Q4 2024), and $595598.3 (Q2 2024), per Business Quant data.

Peer Comparison